171 related articles for article (PubMed ID: 3838315)
1. The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation.
Parker KA; Tollefsen DM
J Biol Chem; 1985 Mar; 260(6):3501-5. PubMed ID: 3838315
[TBL] [Abstract][Full Text] [Related]
2. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition.
Derechin VM; Blinder MA; Tollefsen DM
J Biol Chem; 1990 Apr; 265(10):5623-8. PubMed ID: 2138609
[TBL] [Abstract][Full Text] [Related]
3. Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells.
McGuire EA; Tollefsen DM
J Biol Chem; 1987 Jan; 262(1):169-75. PubMed ID: 3793724
[TBL] [Abstract][Full Text] [Related]
4. Activation of heparin cofactor II by dermatan sulfate.
Tollefsen DM; Pestka CA; Monafo WJ
J Biol Chem; 1983 Jun; 258(11):6713-6. PubMed ID: 6687888
[TBL] [Abstract][Full Text] [Related]
5. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
[TBL] [Abstract][Full Text] [Related]
6. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
Van Deerlin VM; Tollefsen DM
J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
[TBL] [Abstract][Full Text] [Related]
7. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
Blinder MA; Tollefsen DM
J Biol Chem; 1990 Jan; 265(1):286-91. PubMed ID: 2104620
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of meizothrombin and meizothrombin(desF1) by heparin cofactor II.
Han JH; Côté HC; Tollefsen DM
J Biol Chem; 1997 Nov; 272(45):28660-5. PubMed ID: 9353333
[TBL] [Abstract][Full Text] [Related]
9. Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex.
Maekawa H; Sato H; Tollefsen DM
Thromb Res; 2000 Dec; 100(5):443-51. PubMed ID: 11150588
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
Buchanan MR; Brister SJ
Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
[TBL] [Abstract][Full Text] [Related]
12. Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure.
Tollefsen DM; Pestka CA
Blood; 1985 Oct; 66(4):769-74. PubMed ID: 4041618
[TBL] [Abstract][Full Text] [Related]
13. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
Sheehan JP; Tollefsen DM; Sadler JE
J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
[TBL] [Abstract][Full Text] [Related]
14. Contribution of basic residues of the A helix of heparin cofactor II to heparin- or dermatan sulfate-mediated thrombin inhibition.
Hayakawa Y; Hirashima Y; Kurimoto M; Hayashi N; Hamada H; Kuwayama N; Endo S
FEBS Lett; 2002 Jul; 522(1-3):147-50. PubMed ID: 12095635
[TBL] [Abstract][Full Text] [Related]
15. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
[TBL] [Abstract][Full Text] [Related]
16. Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate.
Blinder MA; Andersson TR; Abildgaard U; Tollefsen DM
J Biol Chem; 1989 Mar; 264(9):5128-33. PubMed ID: 2647747
[TBL] [Abstract][Full Text] [Related]
17. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of chymotrypsin by heparin cofactor II.
Church FC; Noyes CM; Griffith MJ
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6431-4. PubMed ID: 3863104
[TBL] [Abstract][Full Text] [Related]
19. [Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role].
Rossi EB; Duboscq CL; Kordich LC
Medicina (B Aires); 1999; 59(1):95-104. PubMed ID: 10349131
[TBL] [Abstract][Full Text] [Related]
20. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin.
Holland CA; Henry AT; Whinna HC; Church FC
FEBS Lett; 2000 Nov; 484(2):87-91. PubMed ID: 11068038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
